Overview

Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer

Status:
Terminated
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
Pharmacokinetic, bioequivalence study
Phase:
Phase 1
Details
Lead Sponsor:
Sun Pharma Advanced Research Company Limited